Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-26 @ 3:16 PM
NCT ID: NCT07451132
Eligibility Criteria: Inclusion Criteria: Adults (range 18 - 60 yrs.) Men and women Performing as a healthcare worker Being a shift-worker for at least 6 months in the current schedule Working in rotating shiftwork, including at least one night shift Reporting no work-related performance difficulties Exclusion Criteria: * Current and chronic neurological disorders * Pathologies related to abnormal adrenal activity * Liver or kidney disease * Uncontrolled hypertension, dyslipidemia, and thyroid disease * Insulin resistance and T2D * BMI ≥40 kg/m2 * Use of medications known to alter body composition, such as insulin sensitizers, glucocorticoids, or anti-depressants * Autoimmune diseases with acute symptoms; recent surgery of any kind (in the last 3 months); * Acute, chronic inflammation (usCRP \>10 mg/L) * Following any dietary restriction (special diet) in the previous three months * Having a short sleep (habitual sleep duration of less than 6h per day) * History of bariatric surgery * Depression (Beck Depression Inventory) or sleep disorders (Pittsburgh Sleep Questionnaire) * Night-eating syndrome (Night Eating Questionnaire) * Intense exercise level (\>3 days/week of high-intensity exercise) * Having traveled across time zones (at any time during the last month) and planning travel during the study * Pregnant or intend to become pregnant, and * Lactating women
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 60 Years
Study: NCT07451132
Study Brief:
Protocol Section: NCT07451132